"programmed cell death 1 ligand 2 protein" trang 2 - tải miễn phí từ tailieunhanh
Establishing a whole blood CD4+ T cell immunity measurement to predict response to anti-PD-1

Establishing a whole blood CD4+ T cell immunity measurement to predict response to anti-PD-1
10    8    1
Báo cáo y học:

Báo cáo y học: " Legionella pneumophila infection induces programmed cell death, caspase activation, and release of high-mobility group box 1 protein in A549 alveolar epithelial cells: inhibition by methyl prednisolone"
10    79    0
Clinical outcome of pembrolizumab for various malignancies in single institute in Vietnam

Clinical outcome of pembrolizumab for various malignancies in single institute in Vietnam
4    69    0
Increased PD-1-positive macrophages in the tissue of gastric cancer are closely associated with poor prognosis in gastric cancer patients

Increased PD-1-positive macrophages in the tissue of gastric cancer are closely associated with poor prognosis in gastric cancer patients
9    100    0
Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): Protocol for a multicenter phase II open label study

Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): Protocol for a multicenter phase II open label study
7    65    0
IFN-γ down-regulates the PD-1 expression and assist nivolumab in PD-1-blockade effect on CD8+ T-lymphocytes in pancreatic cancer

IFN-γ down-regulates the PD-1 expression and assist nivolumab in PD-1-blockade effect on CD8+ T-lymphocytes in pancreatic cancer
11    86    0
Heterogeneity of PD-L1 expression in primary tumors and paired lymph node metastases of triple negative breast cancer

Heterogeneity of PD-L1 expression in primary tumors and paired lymph node metastases of triple negative breast cancer
9    66    1
Prognostic value and clinicopathological characteristics of PD-L1 overexpression in non-Hodgkin lymphoma: A meta-analysis

Prognostic value and clinicopathological characteristics of PD-L1 overexpression in non-Hodgkin lymphoma: A meta-analysis
10    71    1
The prognostic value of PKM2 and its correlation with tumour cell PD-L1 in lung adenocarcinoma

The prognostic value of PKM2 and its correlation with tumour cell PD-L1 in lung adenocarcinoma
12    63    1
‘DURVIT’: A phase-I trial of single low-dose durvalumab (Medi4736) IntraTumourally injected in cervical cancer: Safety, toxicity and effect on the primary tumour and lymph node microenvironment

‘DURVIT’: A phase-I trial of single low-dose durvalumab (Medi4736) IntraTumourally injected in cervical cancer: Safety, toxicity and effect on the primary tumour and lymph node microenvironment
8    71    1
Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: The multicentre prospective Safe Stop trial

Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: The multicentre prospective Safe Stop trial
9    42    1
Nanoparticle albumin-bound paclitaxel and PD-1 inhibitor (sintilimab) combination therapy for soft tissue sarcoma: A retrospective study

Nanoparticle albumin-bound paclitaxel and PD-1 inhibitor (sintilimab) combination therapy for soft tissue sarcoma: A retrospective study
9    55    3
Association of a novel 27-gene immuno-oncology assay with efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer

Association of a novel 27-gene immuno-oncology assay with efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer
10    16    1
Bioinformatic analysis of PD-1 checkpoint blockade response in infuenza infection

Bioinformatic analysis of PD-1 checkpoint blockade response in infuenza infection
13    19    1
Programmed cell death ligand 1 measurement study in granulocyte colony-stimulating factor-producing lung cancer: An observational study

Programmed cell death ligand 1 measurement study in granulocyte colony-stimulating factor-producing lung cancer: An observational study
6    1    1